Tang Yating, Xu Jie, Lu Yi, Zheng Tianyu
Department of Ophthalmology and Eye Research Institute, Eye and ENT Hospital of Fudan University, Shanghai, 200031 China.
NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Science, Shanghai, 200031, China.
Phenomics. 2022 May 7;2(4):254-260. doi: 10.1007/s43657-022-00053-2. eCollection 2022 Aug.
Genetic alterations are a major cause of microphthalmos, while novel-related genes and mutations in microphthalmos have rarely been explored. To identify the underlying genetic defect responsible for microphthalmos eyes in two three-generation Chinese families, we screened 425 genes involved in common inherited non-syndromic eye diseases with next-generation sequencing-based target capture sequencing of the two probands of two three-generation Chinese families diagnosed with microphthalmos. Variants were filtered and analyzed to identify possible disease-causing variants before Sanger sequencing validation. We enrolled two families with microphthalmos (Family 1: microphthalmos with congenital ocular coloboma and Family 2: simple microphthalmos). Two novel heterozygous mutations, Peroxidasin () c.3165C>T (p.Pro1055Pro) and c.2640C>G (p.Arg880Arg), were found in Family 1, and Crystallin Beta B2 () c.481G>A (p.Gly161Arg) was found in Family 2, but none of the mutations were found in the unaffected individuals, who were phenotypically normal. Multiple orthologous sequence alignment (MSA) revealed that the p.Gly161Arg mutation was a deleterious effect mutation. In conclusion, the three novel mutations found in our study extend our current understanding of the genetic basis of microphthalmos and provide early pre-symptomatic diagnosis and emphasize the significance of genetic diagnosis of microphthalmos.
基因改变是小眼症的主要原因,而与小眼症相关的新基因和突变很少被探索。为了确定两个三代中国家庭中小眼症的潜在遗传缺陷,我们对两个被诊断为小眼症的三代中国家庭的两名先证者进行了基于下一代测序的目标捕获测序,筛查了425个与常见遗传性非综合征性眼病相关的基因。在进行Sanger测序验证之前,对变异进行过滤和分析,以确定可能的致病变异。我们纳入了两个患有小眼症的家庭(家庭1:小眼症合并先天性眼裂;家庭2:单纯小眼症)。在家庭1中发现了两个新的杂合突变,过氧化物酶(Peroxidasin)c.3165C>T(p.Pro1055Pro)和c.2640C>G(p.Arg880Arg),在家庭2中发现了βB2晶状体蛋白(Crystallin Beta B2)c.481G>A(p.Gly161Arg),但在表型正常的未受影响个体中未发现任何突变。多序列比对(MSA)显示p.Gly161Arg突变是一种有害效应突变。总之,我们研究中发现的三个新突变扩展了我们目前对小眼症遗传基础的理解,为早期症状前诊断提供了依据,并强调了小眼症基因诊断的重要性。